Brian A. Leuthner, President and CEO at Edge Therapeutics, Inc. (EDGE), sold 5,000 shares at $10.11 ($51K) on 2018-01-02, disclosed to the SEC on 2018-01-03.
Scheduled sale ($51k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.11 | 2,500 | $25K | 50.0% |
| 2 | $10.11 | 2,500 | $25K | 50.0% |
| Total | $10.11 avg | 5,000 | $51K | 100% |
| Filing → |
| EDGE | SELL | 2018-02-23 | $77K | — | Filing → |
| EDGE | SELL | 2018-02-02 | $65K | — | Filing → |
| EDGE | SELL | 2017-12-05 | $74K | — | Filing → |